A multi-center, randomized, prospective study evaluating the optimal radiation dose of definitive concurrent chemoradiation for inoperable esophageal squamous cell carcinoma.

被引：8
|
作者：
Xu, Yanjun
Zhu, Weiguo
Zheng, Xiao
Wang, Wanwei
Li, Jiancheng
Huang, Rong
He, Han
Chen, Jianxiang
Liu, Liping
Sun, Zongwen
Yang, Xinmei
He, Huijuan
Zeng, Ming
Pu, Juan
Hu, Wangyuan
Bao, Yong
Liu, Zhigang
Ma, Jun
Chen, Ming
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Huaian First Peoples Hosp, Huaian, Peoples R China
[3] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Foshan First Peoples Hosp, Foshan, Peoples R China
[5] Jining First Peoples Hosp, Jining, Peoples R China
[6] Jiaxing First Peoples Hosp, Jiaxing, Peoples R China
[7] Quzhou Peoples Hosp, Quzhou, Peoples R China
[8] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China
[9] Lianshui Peoples Hosp, Lianshui, Peoples R China
[10] Jinhua Cent Hosp, Jinhua, Zhejiang, Peoples R China
[11] Sun Yat Sen Univ, Dept Radiat Oncol, Collaborat Innovat Ctr Canc Med, Ctr Canc,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[12] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[13] Anhui Prov Hosp, Hefei, Anhui, Peoples R China
[14] Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4013
引用
收藏
页数：1
相关论文
共 50 条
  • [31] High versus standard radiation dose of definitive chemoradiotherapy combined with immunotherapy for inoperable esophageal squamous cell carcinoma: A multicenter propensity score matching analysis
    Chen, Baoqing
    Chen, Biqi
    Zhang, Hao
    Wang, Bingyi
    Cheng, Qi
    Chen, Wenyan
    Cheng, Xingyuan
    Cen, Peiying
    Liu, Shiliang
    Xi, Mian
    Li, Qiaoqiao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
    Deng, Yuxia
    Bian, Chao
    Tao, Hua
    Zhang, Haijun
    ONCOTARGET, 2017, 8 (45) : 79662 - 79669
  • [33] Phase 2 Study of Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable Locally Advanced Esophageal Squamous Cell Carcinoma
    Wu, K.
    Wang, H.
    Fan, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E199 - E199
  • [34] A single institution retrospective study evaluating mitomycin dosing during chemoradiation in anal squamous cell carcinoma.
    Gong, Jenny
    Simon, Emily
    Selfridge, J. Eva
    Bajor, David L.
    Steinhagen, Emily
    Lumish, Melissa Amy
    Chakrabarti, Sakti
    Mohamed, A. M. R.
    Henke, Lauren E.
    Dorth, Jennifer Anne
    Mahipal, Amit
    Conces, Madison
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 7 - 7
  • [35] Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
    Chengcheng Fan
    Xu Wang
    Xiaoli Zheng
    Yanan Sun
    Ke Ye
    Yue Jiang
    Xiao Liu
    Wencai Xu
    Yang Liu
    Yuanyuan Yang
    Jinsong Liu
    Qiong Jiang
    Chunyu He
    Xiaoyuan Wu
    Xin Nie
    Jingwei Zhang
    Bo Tan
    Wen Wang
    Yougai Zhang
    Zhuo Feng
    Chengliang Yang
    Yufei Lu
    Hailong Liu
    Xijuan Chen
    Jing Xu
    Fang Liu
    Xuefeng Zheng
    Jianhua Wang
    Shang Wu
    Guofu Chen
    Yaowen Zhang
    Linzhi Jin
    Hong Ge
    BMC Cancer, 24
  • [36] Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
    Fan, Chengcheng
    Wang, Xu
    Zheng, Xiaoli
    Sun, Yanan
    Ye, Ke
    Jiang, Yue
    Liu, Xiao
    Xu, Wencai
    Liu, Yang
    Yang, Yuanyuan
    Liu, Jinsong
    Jiang, Qiong
    He, Chunyu
    Wu, Xiaoyuan
    Nie, Xin
    Zhang, Jingwei
    Tan, Bo
    Wang, Wen
    Zhang, Yougai
    Feng, Zhuo
    Yang, Chengliang
    Lu, Yufei
    Liu, Hailong
    Chen, Xijuan
    Xu, Jing
    Liu, Fang
    Zheng, Xuefeng
    Wang, Jianhua
    Wu, Shang
    Chen, Guofu
    Zhang, Yaowen
    Jin, Linzhi
    Ge, Hong
    BMC CANCER, 2024, 24 (01)
  • [37] Concurrent Erlotinib and Radiation Therapy for Chemoradiation Therapy-Intolerant Esophageal Squamous Cell Carcinoma Patients: An Updated Result
    Zhai, Y. R.
    Hui, Z.
    Wang, J.
    Wang, X.
    Liang, J.
    Deng, L.
    Chen, B.
    Lv, J.
    Feng, Q.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E146 - E146
  • [38] Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical Trial
    Yang, Y.
    Wang, C.
    Jiang, Y.
    Zhou, X.
    Wang, S.
    Su, D.
    Qiu, G.
    Chen, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S13 - S13
  • [39] A prospective study of definitive chemoradiation with immunotherapy (CRIO) in locally or regionally advanced, unresectable cutaneous squamous cell carcinoma
    Lin, Charles
    Ng, Gary
    Nottage, Michelle
    Hay, Karen
    Keller, Jacqui
    Pritchard, Wendy
    Hughes, Brett
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 102 - 102
  • [40] Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: A phase I trial (GASTO-1021)
    Chen, Nai-Bin
    Li, Qi-Wen
    Li, Su
    Guo, Su-Ping
    Wu, Ying-Jia
    Cheng, Zhangkai J.
    Li, Ji-Bin
    Wang, Da-Quan
    Liu, Fang-Jie
    Ai, Xin-Lei
    Hu, Nan
    Qiu, Bo
    Liu, Hui
    RADIOTHERAPY AND ONCOLOGY, 2021, 155 : 105 - 112
12345